Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
113.10 USD | -1.14% | +0.30% | +2.75% |
Sep. 05 | Abbott Laboratories' Lingo Glucose Monitor System Available in US | MT |
Sep. 04 | Abbott Launches Trial to Assess Use of Deep Brain Stimulation System to Manage Depression | MT |
Capitalization | 197B | P/E ratio 2024 * |
33.8x | P/E ratio 2025 * | 28.9x |
---|---|---|---|---|---|
Enterprise value | 203B | EV / Sales 2024 * |
4.85x | EV / Sales 2025 * | 4.46x |
Free-Float |
86.97% | Yield 2024 * |
1.96% | Yield 2025 * | 2.11% |
Last Transcript: Abbott Laboratories
1 day | -1.14% | ||
1 week | +0.30% | ||
Current month | -0.15% | ||
1 month | +4.11% | ||
3 months | +9.56% | ||
6 months | -4.54% | ||
Current year | +2.75% |
Director | Title | Age | Since |
---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 50 | 14-12-31 |
Philip Boudreau
DFI | Director of Finance/CFO | 51 | 96-12-31 |
Scott House
CTO | Chief Tech/Sci/R&D Officer | - | 89-12-31 |
Manager | Title | Age | Since |
---|---|---|---|
Robert Alpern
BRD | Director/Board Member | 73 | 08-10-09 |
Sally Blount
BRD | Director/Board Member | 62 | 11-12-08 |
Nancy McKinstry
BRD | Director/Board Member | 65 | 11-12-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.18% | 18 M€ | +7.76% | - | |
5.19% | 2 M€ | -.--% | ||
3.00% | 2 M€ | -.--% | - |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
-1.14% | +0.30% | +12.11% | -12.28% | 197B | ||
-1.80% | +1.36% | +11.46% | -33.60% | 115B | ||
-1.31% | -3.20% | -14.52% | -9.53% | 67.42B | ||
-2.94% | -0.57% | +36.66% | +88.78% | 46.3B | ||
-0.42% | -7.02% | +15.15% | +6.51% | 46.57B | ||
-0.08% | -3.12% | +14.03% | -11.98% | 29.42B | ||
-1.10% | -0.82% | -31.18% | -49.08% | 27.67B | ||
+0.04% | -1.62% | +20.99% | +5.00% | 27.34B | ||
-0.57% | +0.56% | +6.89% | +9.75% | 23.57B | ||
-8.74% | -8.90% | -11.32% | -28.81% | 21.28B | ||
Average | -1.81% | -2.60% | +6.03% | -3.53% | 60.1B | |
Weighted average by Cap. | -1.51% | -1.29% | +8.60% | -7.41% |
Financials
(USD)2024 * | 2025 * | |
---|---|---|
Net sales | 41.74B | 44.77B |
Net income | 5.81B | 6.83B |
Net Debt | 5.85B | 2.69B |
Date | Price | Change | Volume |
---|---|---|---|
24-09-05 | 113.10 $ | -1.14% | 2,928,009 |
24-09-04 | 114.40 $ | -0.23% | 3,659,202 |
24-09-03 | 114.66 $ | +1.23% | 4,436,991 |
24-08-30 | 113.27 $ | +0.45% | 4,320,139 |
24-08-29 | 112.76 $ | -0.12% | 3,375,767 |
Delayed Quote Nyse, September 05, 2024 at 04:00 pm EDT
More quotes- Stock Market
- Equities
- ABT Stock